Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Therapeutic Area
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map
6. Vietnam Pharmaceuticals Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Drug Type (Generic Drugs, Branded Drugs)
6.2.2. By Product Type (Prescription Drugs, Over-The-Counter Drugs)
6.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Company (2024)
6.3. Market Map
7. Northern Vietnam Pharmaceuticals Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Product Type
7.2.3. By Application
7.2.4. By Distribution Channel
8. Central Vietnam Pharmaceuticals Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Product Type
8.2.3. By Application
8.2.4. By Distribution Channel
9. Southern Vietnam Pharmaceuticals Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Product Type
9.2.3. By Application
9.2.4. By Distribution Channel
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments
12. Policy & Regulatory Landscape
13. Vietnam Economic Profile
14. Vietnam Pharmaceuticals Market: SWOT Analysis
15. Porter's Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Bayer Vietnam Ltd.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. DHG Pharmaceutical Joint Stock Company
16.3. Traphaco Joint Stock Company
16.4. Pharmaceutical Corporation Ha Tay
16.5. Domesco Medical Import Export Joint Stock Corporation (DOMESCO)
16.6. OPC Pharmaceutical Joint Stock Company
16.7. Sanofi Vietnam
16.8. Mekophar Chemical and Pharmaceutical JSC
16.9. Imexpharm Pharmaceutical Joint Stock Company
16.10. Pymepharco Joint Stock Company
17. Strategic Recommendations
18. About Us & Disclaimer